Integrins in Human Anterior Chamber Angle
Overview
Authors
Affiliations
Background: Integrins, which are composed of an alpha and beta subunit, are capable of binding to a number of extracellular matrix proteins and, hence, affect cell adhesion and proliferation.
Methods: The distribution of the integrin beta (beta 1, beta 3-beta 5) and alpha (alpha 1-6 and alpha v) subunits in human anterior chamber angle was studied in eyes from subjects aged 9 months to 81 years using the indirect immunofluorescence technique.
Results: Immunoreaction for the beta 1 subunit was found throughout the trabecular meshwork (TM), in the cribriform layer, and in the endothelial lining of Schlemm's canal (SC). Labelling for the alpha 3 subunit was found in the TM and the cribriform layer only. In infant eyes the alpha 5 subunit was present in all three areas with the highest concentration in the cribriform layer, whereas no reaction was observed in adult eyes. The alpha 6 subunit was localized to the endothelium of SC only. Immunoreaction for the alpha v subunit was present in the TM and the cribriform layer of infants and young adults.
Conclusion: The present results suggest the presence of several integrin heterodimers, acting as potential receptors for laminin, collagen, fibronectin, and vitronectin, in the anterior chamber angle.
Aqueous outflow regulation - 21st century concepts.
Johnstone M, Xin C, Tan J, Martin E, Wen J, Wang R Prog Retin Eye Res. 2020; 83:100917.
PMID: 33217556 PMC: 8126645. DOI: 10.1016/j.preteyeres.2020.100917.
The role of integrins in glaucoma.
Filla M, Faralli J, Peotter J, Peters D Exp Eye Res. 2016; 158:124-136.
PMID: 27185161 PMC: 5612317. DOI: 10.1016/j.exer.2016.05.011.
Hann C, Fautsch M Curr Ophthalmol Rep. 2015; 3(2):67-73.
PMID: 26236568 PMC: 4520696. DOI: 10.1007/s40135-015-0072-x.
Vranka J, Kelley M, Acott T, Keller K Exp Eye Res. 2015; 133:112-25.
PMID: 25819459 PMC: 4379427. DOI: 10.1016/j.exer.2014.07.014.
The role of integrins in the trabecular meshwork.
Gagen D, Faralli J, Filla M, Peters D J Ocul Pharmacol Ther. 2013; 30(2-3):110-20.
PMID: 24266581 PMC: 3991962. DOI: 10.1089/jop.2013.0176.